Acute psychological stress modulates the expression of enzymes involved in the kynurenine pathway throughout corticolimbic circuits in adult male rats

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Vecchiarelli, Haley A ^a,b   Gandhi, Chaitanya P ^a,b   Hill, Matthew N ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; KYNURENINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; QUINOLINIC ACID;

ADULT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOLIMBIC CIRCUIT; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; LIMBIC CORTEX; MALE; MEDIAL PREFRONTAL CORTEX; MENTAL STRESS; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; BRAIN; GENETICS; LIMBIC SYSTEM; METABOLISM; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BRAIN; CORTICOSTERONE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENIC ACID; KYNURENINE; LIMBIC SYSTEM; MALE; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 84957054280     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/7215684     Document Type: Article

References (36)

1. R. Schwarcz, J. P. Bruno, P. J. Muchowski, and H.-Q. Wu, "Kynurenines in the mammalian brain: when physiology meets pathology," Nature Reviews Neuroscience, vol. 13, no. 7, pp. 465-477, 2012.
2. L. Capuron, A. Ravaud, P. J. Neveu, A. H. Miller, M. Maes, and R. Dantzer, "Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy," Molecular Psychiatry, vol. 7, no. 5, pp. 468-473, 2002.
3. C. Kohl, T. Walch, R. Huber et al., "Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues," Journal of Affective Disorders, vol. 86, no. 2-3, pp. 135-142, 2005.
4. B. E. Leonard and A. Myint, "Changes in the immune system in depression and dementia: causal or coincidental effects?" Dialogues in Clinical Neuroscience, vol. 8, no. 2, pp. 163-174, 2006.
5. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, E. Bosmans, and S. Scharpé, "Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation," Life Sciences, vol. 71, no. 16, pp. 1837-1848, 2002.
6. A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin, "Neuroendocrine-immunemechanisms of behavioral comorbidities in patients with cancer," Journal of Clinical Oncology, vol. 26, no. 6, pp. 971-982, 2008.
7. H. Miura, N. Ozaki, M. Sawada, K. Isobe, T. Ohta, and T. Nagatsu, "A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression," Stress, vol. 11, no. 3, pp. 198-209, 2008.
8. A.-M. Myint, Y. K. Kim, R. Verkerk, S. Scharpé, H. Steinbusch, and B. Leonard, "Kynurenine pathway in major depression: evidence of impaired neuroprotection," Journal of Affective Disorders, vol. 98, no. 1-2, pp. 143-151, 2007.
9. W. Swardfager, N. Herrmann, Y. Dowlati et al., "Indoleamine 2, 3-dioxygenase activation and depressive symptoms in patients with coronary artery disease," Psychoneuroendocrinology, vol. 34, no. 10, pp. 1560-1566, 2009.
10. P. A. Zunszain, C. Anacker, A. Cattaneo, L. A. Carvalho, and C. M. Pariante, "Glucocorticoids, cytokines and brain abnormalities in depression," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 722-729, 2011.
11. B. Leonard and M. Maes, "Mechanistic explanations how cellmediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression," Neuroscience and Biobehavioral Reviews, vol. 36, no. 2, pp. 764-785, 2012.
12. A. M. Myint, "Kynurenines: from the perspective of major psychiatric disorders," The FEBS Journal, vol. 279, no. 8, pp. 1375-1385, 2012.
13. J. Steiner, B. Bogerts, Z. Sarnyai et al., "Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity," The World Journal of Biological Psychiatry, vol. 13, no. 7, pp. 482-492, 2012.
14. T. Deak, K. A. Bordner, N. K. McElderry et al., "Stress-induced increases in hypothalamic IL-1: a systematic analysis ofmultiple stressor paradigms," Brain Research Bulletin, vol. 64, no. 6, pp. 541-556, 2005.
15. N. Rohleder, "Stimulation of systemic low-grade inflammation by psychosocial stress," Psychosomatic Medicine, vol. 76, no. 3, pp. 181-189, 2014.
16. H. A. Vecchiarelli, C. P. Gandhi, J. M. Gray, M. Morena, K. I. Hassan, and M. N. Hill, "Divergent responses of inflammatory mediators within the amygdala and medial prefrontal cortex to acute psychological stress," Brain, Behavior, and Immunity, 2015.
17. C. Kiank, J.-P. Zeden, S. Drude et al., "Psychological stressinduced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans," PLoS ONE, vol. 5, no. 7, Article IDe11825, 2010.
18. H. Miura, Y. Ando, Y. Noda, K. Isobe, and N. Ozaki, "Longlasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice," Stress, vol. 14, no. 3, pp. 262-272, 2011.
19. D. Pawlak, Y. Takada, T. Urano, and A. Takada, "Serotonergic and kynurenic pathways in rats exposed to foot shock," Brain Research Bulletin, vol. 52, no. 3, pp. 197-205, 2000.
20. C. Cearley, L. Churchill, and J. M. Krueger, "Time of day differences in IL1β and TNFα mRNA levels in specific regions of the rat brain," Neuroscience Letters, vol. 352, no. 1, pp. 61-63, 2003.
21. A. Arjona and D. K. Sarkar, "Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells," Journal of Immunology, vol. 174, no. 12, pp. 7618-7624, 2005.
22. A. Nakao, "Temporal regulation of cytokines by the circadian clock," Journal of Immunology Research, vol. 2014, Article ID 614529, 4 pages, 2014.
23. M. N. Hill, I. N. Karatsoreos, C. J. Hillard, and B. S. McEwen, "Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo," Psychoneuroendocrinology, vol. 35, no. 9, pp. 1333-1338, 2010.
24. R. Schwarcz and R. Pellicciari, "Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities," Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 1, pp. 1-10, 2002.
25. H. J. Motulsky and R. E. Brown, "Detecting outliers when fitting data with nonlinear regression-a new method based on robust nonlinear regression and the false discovery rate," BMC Bioinformatics, vol. 7, article 123, 2006.
26. C. C. Pritchard, L. Hsu, J. Delrow, and P. S. Nelson, "Project normal: defining normal variance in mouse gene expression," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 13266-13271, 2001.
27. U. Alon, "Network motifs: theory and experimental approaches," Nature Reviews Genetics, vol. 8, no. 6, pp. 450-461, 2007.
28. J. W. K. Ho, M. Stefani, C. G. dos Remedios, and M. A. Charleston, "Differential variability analysis of gene expression and its application to human diseases," Bioinformatics, vol. 24, no. 13, pp. i390-i398, 2008.
29. G. I. Byrne, L. K. Lehmann, J. G. Kirschbaum, E. C. Borden, C. M. Lee, and R. R. Brown, "Induction of tryptophan degradation in vitro and in vivo: a γ-interferon stimulated activity," Journal of Interferon Research, vol. 6, no. 4, pp. 389-396, 1986.
30. A. R. Green, T. L. Sourkes, and S. N. Young, "Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils," British Journal of Pharmacology, vol. 53, no. 2, pp. 287-292, 1975.
31. A. Laugeray, J.-M. Launay, J. Callebert, A. Surget, C. Belzung, and P. R. Barone, "Peripheral and cerebralmetabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression," Behavioural Brain Research, vol. 210, no. 1, pp. 84-91, 2010.
32. A. Laugeray, J.-M. Launay, J. Callebert, A. Surget, C. Belzung, and P. R. Barone, "Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety-and depression-like behaviours in mice: focus on individual differences," Pharmacology Biochemistry and Behavior, vol. 98, no. 1, pp. 161-168, 2011.
33. S. Rosi, V. Ramirez-Amaya, A. Vazdarjanova, P. F. Worley, C. A. Barnes, and G. L. Wenk, "Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression," Journal of Neuroscience, vol. 25, no. 3, pp. 723-731, 2005.
34. S. Sugama, M. Fujita, M. Hashimoto, and B. Conti, "Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18," Neuroscience, vol. 146, no. 3, pp. 1388-1399, 2007.
35. E. S. Wohleb, N. D. Powell, J. P. Godbout, and J. F. Sheridan, "Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior," The Journal of Neuroscience, vol. 33, no. 34, pp. 13820-13833, 2013.
36. E. Sibille, Y. Wang, J. Joeyen-Waldorf et al., "A molecular signature of depression in the amygdala," The American Journal of Psychiatry, vol. 166, no. 9, pp. 1011-1024, 2009.